Major impact of prognosis by age and sex in patients with primary mediastinal large B‑cell lymphoma

  • Hsuan Jen Shih
  • , Ming Chung Kuo
  • , Tung Liang Lin
  • , Hsiao Wen Kao
  • , Jin Hou Wu
  • , Yu Shin Hung
  • , Che Wei Ou
  • , Yi Jiun Su
  • , Hung Chang*
  • *Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

1 Scopus citations

Abstract

The effective prognostic factors for primary mediastinal large B-cell lymphoma (PMLBCL) vary among published studies. The aim of the present study was to explore the factors influencing the overall survival (OS) and progression-free survival (PFS) of patients with PMLBCL at a single institute in Taiwan. This retrospective study was conducted to analyze the prognostic impact of age, sex, disease stage, International Prognostic Index (IPI) score, treatment modality and initial response. A total of 72 patients with a median age of 28 years were included in the study. The mean OS and PFS were 171.40 and 159.77 months, respectively. Female sex, age ≤60 years, receiving radiotherapy (RT) and achieving a complete response were found to be associated with a significantly improved OS and PFS.

Original languageEnglish
Article number57
JournalOncology Letters
Volume27
Issue number2
DOIs
StatePublished - 02 2024
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2024 The Author(s).

Keywords

  • age
  • primary mediastinal large B cell lymphoma
  • prognosis
  • sex

Fingerprint

Dive into the research topics of 'Major impact of prognosis by age and sex in patients with primary mediastinal large B‑cell lymphoma'. Together they form a unique fingerprint.

Cite this